Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
The Neuromuscular Junction01:19

The Neuromuscular Junction

The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Therapeutic Outcomes in Spinal Muscular Atrophy: An Indian Experience.

Annals of Indian Academy of Neurology·2025
Same author

Hereditary Antithrombin Deficiency Presenting with Cerebral Venous Thrombosis in Three Members of a Family.

Neurology India·2023
Same author

Spontaneous haemarrhagic transformation of an ischemic cerebral infarct : a case report.

Neurology India·2018
Same author

Neurological manifestations in hypoparathyroidism.

Neurology India·2018
Same author

Symptomatic spinal haemangioma : radiological aspects.

Neurology India·2018
Same author

Acute Disseminated Encephalomyelitis Presenting as an Isolated Mesodiencephalic Junction Lesion.

Journal of neurosciences in rural practice·2017

Related Experiment Video

Updated: Jul 2, 2026

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
08:41

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Published on: August 14, 2021

Neuromuscular junctional disorders.

A S Girija1, V V Ashraf

  • 1Department of Neurology, Malabar Institute of Medical Sciences, Calicut, Kerala, India. asgirija@gmail.com

Indian Journal of Pediatrics
|August 22, 2008
PubMed
Summary
This summary is machine-generated.

Diagnosing pediatric neuromuscular junction disorders, including Myasthenia Gravis (MG) and Congenital Myasthenic Syndrome (CMS), requires careful electrophysiological studies and antibody testing. Differentiating these conditions is crucial for effective treatment, as immunotherapy benefits MG but not CMS.

More Related Videos

Characterization of Neuromuscular Junctions in Mice by Combined Confocal and Super-Resolution Microscopy
11:03

Characterization of Neuromuscular Junctions in Mice by Combined Confocal and Super-Resolution Microscopy

Published on: December 8, 2021

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

Related Experiment Videos

Last Updated: Jul 2, 2026

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
08:41

Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions

Published on: August 14, 2021

Characterization of Neuromuscular Junctions in Mice by Combined Confocal and Super-Resolution Microscopy
11:03

Characterization of Neuromuscular Junctions in Mice by Combined Confocal and Super-Resolution Microscopy

Published on: December 8, 2021

Measuring Neuromuscular Junction Functionality
10:40

Measuring Neuromuscular Junction Functionality

Published on: August 6, 2017

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Clinical Electrophysiology

Background:

  • Neuromuscular junction (NMJ) disorders in children present unique diagnostic challenges, often complicated by a high incidence of seronegative Myasthenia Gravis (MG).
  • The presence of MuSK antibodies in a significant proportion of seronegative pediatric MG cases further complicates diagnosis.
  • Congenital Myasthenic Syndromes (CMS), rare hereditary disorders of neuromuscular transmission (NMT), must be distinguished from acquired NMJ disorders due to their lack of response to immunotherapy.

Purpose of the Study:

  • To highlight the diagnostic complexities of pediatric neuromuscular junction disorders.
  • To emphasize the importance of differentiating between acquired NMJ disorders like MG and hereditary CMS.
  • To discuss the role of specific diagnostic tools and potential therapeutic strategies for CMS.

Main Methods:

  • Detailed electrophysiological studies, including slow and high-rate repetitive nerve stimulation.
  • Assessment of response to anticholinesterases.
  • Estimation of acetylcholine receptor antibodies.
  • Consideration of MuSK antibody positivity in seronegative cases.
  • Molecular genetic studies for identifying specific CMS types.

Main Results:

  • Pediatric NMJ disorders can manifest as floppy infant syndrome.
  • Electrophysiological studies are key diagnostic tools.
  • MuSK antibody positivity is relevant in seronegative pediatric MG.
  • Molecular genetics aids in CMS subtyping and guides targeted therapies (e.g., Fluoxetine, Quinidine).

Conclusions:

  • Accurate diagnosis of pediatric NMJ disorders hinges on comprehensive electrophysiological assessments and antibody testing.
  • Distinguishing between acquired MG and hereditary CMS is critical for appropriate management.
  • Identifying specific CMS subtypes through molecular genetics allows for targeted pharmacological interventions beyond standard immunotherapy.